Woodford Investment Management as of Sept. 30, 2017
Portfolio Holdings for Woodford Investment Management
Woodford Investment Management holds 7 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena (PRTA) | 33.7 | $735M | 11M | 64.77 | |
| Alkermes (ALKS) | 17.1 | $373M | 7.3M | 50.84 | |
| Theravance Biopharma (TBPH) | 16.8 | $367M | 11M | 34.24 | |
| Abbvie (ABBV) | 15.8 | $344M | 3.9M | 88.86 | |
| Gilead Sciences (GILD) | 6.2 | $135M | 1.7M | 81.02 | |
| Biogen Idec (BIIB) | 5.2 | $113M | 360k | 313.12 | |
| Bioverativ Inc Com equity | 5.1 | $112M | 2.0M | 57.07 |
